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Abstract
Background: Nutritional control of gene regulation guides the transformation of smooth muscle cells (SMC) into
foam cells in atherosclerosis. Oxidative stress has been reported in areas of lipid accumulation, activating
proliferation genes. Suppression of oxidative stress by antioxidant administration reduces this activation and the
progression of lesions. We hypothesized that fish oil consumption may protect against atherosclerotic vascular
disease. The study objective was to determine the effects of dietary cholesterol and fish-oil intake on the apoptotic
pathways induced by 25-hydroxycholesterol (25-HC) in SMC cultures.
Methods: An in vivo/in vitro cell model was used, culturing SMC isolated from chicks exposed to an atherogenic
cholesterol-rich diet with 5% of cholesterol (SMC-Ch) alone or followed by an anti-atherogenic fish oil-rich diet
with 10% of menhaden oil (SMC-Ch-FO) and from chicks on standard diet (SMC-C). Cells were exposed to 25-HC,
studying apoptosis levels by flow cytometry (Annexin V) and expressions of caspase-3, c-myc, and p53 genes by
quantitative real-time reverse transcriptase-polymerase chain reaction. Results: Exposure to 25-HC produced
apoptosis in all three SMC cultures, which was mediated by increases in caspase-3, c-myc, and p53 gene
expression. Changes were more marked in SMC-Ch than in SMC-C, indicating that dietary cholesterol makes SMC
more susceptible to 25-HC-mediated apoptosis. Expression of p53 gene was elevated in SMC-Ch-FO. This supports
the proposition that endogenous levels of p53 protect SMC against apoptosis and possibly against the
development of atherosclerosis. Fish oil attenuated the increase in c-myc levels observed in SMC-C and SMC-Ch,
possibly through its influence on the expression of antioxidant genes.
Conclusion: Replacement of a cholesterol-rich diet with a fish oil-rich diet produces some reversal of the
cholesterol-induced changes, increasing the resistance of SMC to apoptosis.
Background
Gene expression is influenced by dietary fat [1], gene
transcription is regulated by dietary polyunsaturated
fatty acids [2], and the nutritional control of gene regu-
lation guides the transformation of SMC into foam cells
in atherosclerosis [3]. The present study focused on the
effect of cholesterol and fish oil intake on the expression
of apoptosis-regulating caspase-3, c-myc and p53 genes.
In the 1970 s, a very low incidence of death from
ischemic heart disease was observed in Greenland
Eskimos, who have a high fish consumption [4]. Evi-
dence from several research lines supports the hypoth-
esis that fish consumption may protect against
atherosclerotic vascular disease. Fish oil inhibits devel-
opment of atherosclerosis in rhesus monkeys, rabbits,
and humans [5-7], the n-3 fatty acids present in fish oil
also have several biological effects that may be anti-
atherogenic. In the last decade evidence had been pro-
vided, that other fatty acids compounds are responsible
for the positive effects of fish oil, e.g. furan FA (F-acids).
F-acids are generated in large amounts in algae, but
they are also produced by plants and microorganisms.
Fish and other marine organisms as well as mammals
consume F-acids in their food and incorporate them
into phospholipids and cholesterol esters. The
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any medium, provided the original work is properly cited.biogenetic precursor of the most abundant F-acid, F6, is
linoleic acid. F-acids react readily with peroxyl radicals
to generate dioxoenes. The radical-scavenging ability of
F-acids may contribute to the protective properties of
fish and fish oil diets against mortality from heart dis-
ease. [8]. However, the mechanism by which fish oil
exert their effects is not fully understood. It has been
proposed that some of these effects occur via plasma
lipids [9]. It is well established that menhaden oil sup-
plementation of the diet of chicks produced drastic
reductions in plasma cholesterol, VLDL, and low- and
high-density lipoprotein (LDL and HDL) fractions [9].
Supplementation with 10% menhaden oil was also
reported [10] to drastically inhibit of 3-hydroxy-3-
methylglutaryl-CoA (HMG_CoA) reductase activity in
neonatal chick liver. In another study, supplementation
of neonate chick diet with 10% menhaden oil for 7 days
resulted in a significant hypocholesterolemia and hypo-
triglyceridemia [11].
However, the effects of fish oil on the regulation of
apoptosis are less well known [6]. It has been reported
that free cholesterol loading of macrophages induces
apoptosis in atherosclerosis [12,13] and that apoptosis
decreases after lipid lowering [14]. Furthermore,
smooth muscle cells (SMC) in atherosclerotic plaques
can be lost via apoptosis [15], destabilizing plaque and
increasing the risk of thrombosis. The decision phase
of apoptosis involves the expression of specific pro-
and anti-apoptotic genes. If the sum of signals gives
a p o p t o s i sa sar e s u l t ,t h ee n tire protein machinery for
destruction is unleashed. In SMC, apoptosis can be
promoted by deregulation of the expression of c-myc
or E2F [16], which in turn can be regulated by p53.
The expression of p53 alone can promote apoptosis in
SMC [17]. In atherosclerosis, SMC are highly suscepti-
ble to p53-mediated apoptosis [18].
25-hydroxycholesterol (25-HC) induced apoptosis in a
leukemia model system [19], and 25-HC treatment
repressed expression of the proto-oncogene c-myc, an
early response gene [20,21] whose product, c-Myc, is
critical for the control of cell proliferation and differen-
tiation [22]. It has also been reported that oxLDL and
a-tocopherol may influence c-Myc activation in human
coronary SMC [23]. Enhanced expression of c-Myc
mRNA was observed in human SMC cultured from aor-
tic plaques [24], carotid atherosclerotic lesions [25], and
vein graft hyperplasia [26]. The tumor suppressor gene
p53 encodes a transcription factor that activates genes
involved in growth arrest (p21, GADD45) and apoptosis
(Bax, Fas, p53-induced genes) [27]. p53 induces apopto-
sis by transcriptional activation of proapoptotic genes/
repression of anti-apoptotic genes and also via non-
transcriptional mechanisms. The cellular response to
p53 depends on the cell type and p53 expression level
and on the presence of other apoptotic stimuli. Thus,
low-level p53 expression often induces growth arrest,
whereas apoptosis is only induced by higher expression
levels. The induction of growth arrest may also reduce
the sensitivity of cells to apoptosis [27]. In human ather-
osclerosis, p53 expression is negatively correlated with
cell proliferation markers [28]. Endogenous p53 levels
protect vascular SMC and stromal cells against apopto-
sis while promoting apoptosis in macrophages, and they
protect against atherosclerosis development [29]. It was
reported that p53 is highly expressed in atherosclerotic
lesions and is involved in oxidized LDL-induced apopto-
sis [30].
Our group has developed an experimental culture
model of SMC isolated from aorta of cholesterol-fed
chicks (Ch-SMC) and control chicks on a standard diet
(C-SMC) cultured under the same conditions. It has
proven suitable for in vitro study of the transformation
into foam cells of SMC induced in vivo by cholesterol
diet, isolating the cells before plaque formation [31].
Previous results with this model showed marked differ-
ences in proliferation and synthesis of DNA, RNA and
protein between Ch-SMC and C-SMC, and these cell
lines differed in lipid (especially cholesterol) synthesis
and in the effects of inhibition on the first step of cho-
lesterol biosynthesis [31,32]. In another study, Ch-SMC
and C-SMC cultures showed altered HMG-CoA reduc-
tase activity and gene expression at transcriptional level
[33]. Hence, a high-cholesterol diet induced changes in
the HMG-CoA reductase gene expression in aortic SMC
of the chicks. The HMG-CoA reductase mRNA concen-
tration in SMC cultures showed a marked rise after
feeding that was not correlated with the fluctuation of
activity observed during feeding of the cells for 72 h
[34].
The hypothesis of this study was that vascular SMC
apoptosis gene expression may be affected during early
atherosclerosis in the in vivo/in vitro SMC culture
model of chick experimental hypercholesterolemia and
that fish oil supplementation after cholesterol dietary
could change these results. We previously character-
ized 25OHC-induced SMC apoptosis by studying anti-
apoptotic and proapoptotic (bcl-2, bcl-xl and bax)
gene expression [35]. The objective of the present
study was to characterize 25-HC-induced SMC apop-
tosis by studying of caspase-3, c-myc, and p53 gene
expression in SMC-C, SMC-Ch, and SMC-Ch-FO cul-
tures. SMC-Ch-FO cultures were isolated from aorta
of chicks fed with high-cholesterol diet for 10 days
and then with standard diet supplemented with 10%
fish oil for a further 10 days. The results showed that
the effects of the cholesterol diet on the expression of
these genes were reversed by dietary supplementation
with fish oil.
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Animals
The protocol of this study was approved by the Animal
Laboratory Service of the University of Granada (Spain),
and the chicks received humane treatment according to
the regulations for Animal Research of the European
Union. Newborn White Leghorn male chicks (Gallus
domesticus), supplied by the Animal Laboratory Service
of the University of Granada, were kept in a chamber
with a light cycle from 9 am to 9 pm and controlled
temperature of 29-31°C with food and water available
ad libitum.
Diet and treatment
The diet was started at hatching and maintained until
the chicks were killed at 20 days. Water was always
available. None of the chicks died a natural death during
the treatment or developed any disease. Three groups of
20-day-old chicks were used: control diet group (C-
group), kept on a standard diet (Sanders A-00); Ch-
treatment group (Ch-group), fed on the same diet sup-
plemented with 5% w/w powdered cholesterol mixed
homogeneously (Panreac reagent Barcelona, pure grade);
a n daC h - f i s ho i lg r o u p( C h -FO-group), fed for 10 days
with the 5% cholesterol-supplemented diet and then for
a further 10 days with the standard diet supplemented
with 10% fish (menhaden) oil. Experimental diets were
prepared daily to minimize oxidation. The standard diet
contained (w/w) 42% carbohydrate (mainly starch), 3.5%
fat and 20.5% protein. The fatty acid composition of the
diets is given in Table 1[11]. No significant differences
in fatty acid composition were found among the diets.
After the treatments, animals were anaesthetized with
ketamine (60 mg/kg of body weight) and sodium pento-
barbital (50 mg/kg of body weight) before decapitation
and removal of the aortic arch. No animals suffered at
any stage of the experiment, and the study protocol was
approved by the ethics committee of our university.
Smooth muscle cell culture
SMC were isolated from the aortic arch of the chicks as
described elsewhere with slight modifications [31] and
cultured in Dulbecco’s Modification of Eagle’sM e d i u m
(DMEM) supplemented with D-glucose (4.5 g/l), L-glu-
tamate (0.584 g/ml), antibiotic cocktail composed of
penicillin (100 mg/ml) and amphotericin (0.25 mg/ml)
(Sigma-Aldrich, Inc), and 10% (v/v) fetal bovine serum
(FBS). Medium was buffered with bicarbonate, and cul-
tures were kept at 37°C in humidified atmosphere (95%
air, 5% CO2). Media were renewed three times a week.
Secondary cultures were initiated after either low
or high passages using 0.05%/0.02% Trypsin-EDTA
solution. All experiments were conducted using 3 or
5 passages. Cells were identified as vascular SMC by
their hill-and-valley configuration at confluence and
positive fluorescence staining for smooth muscle actin
and myosin.
25-hydroxycholesterol treatment and cytotoxicity assay
Cytotoxicity was analyzed by using the MTT assay (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium, bro-
mide; Sigma). SMC were plated in 96-well plates at a
density of 25 000 cells/well. After adhering during over-
night culture, cells were treated for 24 and 48 h with
25-HC (5-40 μg/ml) dissolved in absolute ethanol. The
final concentration of ethanol in the culture medium
never exceeded 0.8% and no effect on culture was
observed at or below this concentration.
MTT was dissolved in DMEM at a concentration of 5
mg/ml. An amount of this solution equal to 10% of the
culture medium volume was added to cell cultures.
Table 1 Fatty acid composition of control and
experimental diet
Fatty acid Control + 10% fish Oil
14 0.8 6.6
16 22.3 22.3
18 8.6 5.8
Total sat. 31.7 34.8
16:1 n-7 3.3 9.2
18:1 n-9 32.4 19.5
20:1 n-9 0.0 0.4
Total MUFA 35.7 29.1
18:2 n-6 24.6 10.7
20:2 n-6 2.5 2.4
20:3 n-6 1.1 0.6
20:4 n-6 1.6 1.4
Total n-6 29.8 15.1
18:3 n-3 0.8 0.6
20:5 n-3 0.0 12.0
22:5 n-3 1.7 1.6
22:6 n-3 0.0 6.8
Total n-3 2.5 21.0
Total PUFA 32.3 36.1
Total unsat. 68.0 65.2
Sat./unsat. 0.47 0.53
Sat./PUFA 0.98 0.96
20:5/22:6 0.00 1.76
n-3/n-6 0.08 1.39
Source: Castillo et all [11]
Results (% fatty acid) are the means of 3 determinations.
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and washed with PBS. The formazan crystals were solu-
bilized by adding 200 μl of solubilization solution (0.05
N HCl in isopropanol). Metabolic activity was quantified
by subtracting light absorbance at 630 nm from absor-
bance at 570 nm.
Apoptosis Assays by Flow Cytometry
Apoptotic cell death in SMC was assessed by flow cyto-
metry (Annexin V-FLUOS Staining Kit, Roche). The
culture medium of each plate (containing cells detached
during the cell death process) was recovered in a tube,
and the cells were suspended by a brief trypsinization
(0.05% with EDTA) and washed twice with cold PBS.
Cells were then resuspended in 100 μLo f1 xb i n d i n g
buffer (10 mM Hepes, pH 7.4, 150 mM NaCl, 2.5 CaCl2,
1m MM g C l 2,4 % B S A )t oad e n s i t yo f1×1 0
6 cells/ml
with annexin V-fluorescein isothiocyanate (FITC) (0.5
μg/ml). Cells were gently mixed and incubated for 15
min at room temperature in the dark. They were then
re-suspended in 1x binding buffer, and propidium iodide
(PI) (0.6 μg/mL) at 4°C was added to each tube before
analysis. Fluorescence was induced with the 488-nm
argon laser and monitored at 512 nm (FL1) for the
FITC signal and 620 nm (FL2) for IP fluorescence on
FACS Vantage (Becton Dickinson Immunocytometry
System, San José, CA.). The log of annexin V-FITC
fluorescence was plotted against the log of IP
fluorescence.
Real-Time PCR Analysis
Total RNA was isolated with Tri-Reagent/Trizol (Invi-
trogen, Ltd, UK). Single-stranded cDNA was synthesized
from 4 μg total RNA using an Oligo(dT)12-18 as primer
and PowerScript™ reverse transcriptase (Clontech
Laboratories, Inc., CAL). Real-time PCR was performed
with the Fast Start DNA Master SYBR Green I Kit
(Roche) and Light Cycler system (Roche). For the Light
Cycler reaction, a master mix of the following reaction
components was prepared to the indicated final concen-
tration: 12.6 μLH 2O, 2.4 μlM g C l 2 (4 mM), 1 μLf o r -
ward primer (0.5 μM), 1 μL reverse primer (0.5 μM),
and 2.0 μL of the Fast Start DNA Master SYBR Green I
mix (Roche). The primer sequences used in this study
are listed in Table 2 and were optimized at an annealing
temperature of 55°C. The cDNA of the genes studied in
the different samples (treated in vivo and in vitro)w e r e
diluted 1:100 and amplified to obtain the Cp value for
each sample. Light Cycler products of the different gene
expressions were analyzed by agarose gel electrophor-
esis, and a Light Cycler melting curve was constructed
to test for a single product at the end of each PCR reac-
tion. A mathematical model developed by Pfaffl [36] was
used for the relative quantification of caspase 3, c-myc,
and p53 mRNA expression in real-time PCR with
respect to the reference b-actin gene transcript.
Statistical analysis
Results are expressed as mean ± SEM. Data were ana-
lyzed by Student’s t-test or, when the variances of two
datasets significantly differed, by Welch’s alternate t-test
InStat statistical package was used for the data analyses.
A p-value ≤ 0.05 was considered significant.
Results
25-hydroxycholesterol induces apoptosis in the three cell
cultures types
The percentage apoptosis was quantified in the three
types of SMC cultures (C, Ch, and Ch-FO) after in vivo
treatments (baseline) and after in vitro treatments. Fig-
ure 1 depicts the flow cytometry results and the percen-
tage of annexin V-FITC-positive cells; the percentages
in the upper right and lower left quadrants of the Figure
represent the SMC in early and late apoptosis at base-
line and after 24-h incubation with 20 μg/ml 25-hydro-
xycholesterol, respectively. At baseline, the SMC showed
a very low level of apoptosis (about 4%)
Cells showed a marked increase in apoptosis after the
addition of 25-HC (p < 0.001), with a higher increase in
SMC-Ch than in SMC-C (p < 0.01).
Expression of c-myc, p53, and caspase-3 genes in the cell
culture model
At baseline, no significant difference in c-myc expres-
sion (Figure 2) was observed among SMC-C, SMC-Ch
or SMC-Ch-FO. The expression of p53 gene (Figure 3)
was significantly higher in SMC-Ch-FO than in the
other two cultures (p < 0.001). None of the SMC
Table 2 Primer sequences and PCR product lengths for b-actin, caspase 3 c-myc and p53
Gene Forward primer Reverse primer length
a-actin
ab-actin
GCTCCGGCAATGTGCAA AGGTTCATGAGGTAGT 515
c-myc AGCGAACGAGTCTGAATCCAGC TTCAACTGTTCTCTCTCCTCCGCC 476
p53 ATGTGCAACAGTTCCTGCAT AGTTCTCCTCCTCGATCTTG 160
caspase 3
3-3
TTAGATTCTGGTATTGAAGC GAAATCCTGTCGAGTGGAGCAGG 269
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Page 4 of 9Figure 1 Apoptosis induced by 25-Hidroxicholesterol in the cell culture model. Cells were labeled with Annexin V-FITC and PI (propidiun
iodide), and apoptosis was assessed by flow cytometry. A, Representative scatter plots of PI (y-axis) versus Annexin V-FITC (x-axis). SMC-C (1),
SMC-Ch (2), SMC-Ch-FO (3), SMC-C treated with 20 μg/ml 25-hydroxycholesterol (25-HC) for 24 h (4), SMC-Ch treated with 20 μg/ml 25-HC for 24
h (5), and SMC-Ch-FO treated with 20 μg/ml 25-HC for 24 h (6). Absence of both markers (lower left quadrants) indicates viable cells; PI positive
alone (upper left quadrants) indicates cell necrosis, whereas Annexin V staining alone or together with PI (upper right and lower right quadrants)
indicates of early- and late-stage apoptosis, respectively. B, Summary data of three experiments showing the % of annexin-V positive cells (upper
right and lower right quadrants) in SMC cultures at baseline (SMC-C, SMC-Ch, and SMC-Ch-FO) and after 24-h treatment in vitro with 20 μg/ml
25-HC for 24 h. *P < 0.05, ** P < 0.01, *** P < 0.001 vs. SMC-C, +P < 0.05, ++P < 0.01, +++ P < 0.001 vs. SMC-C treated with 20 μg/ml 25-HC for
24 h.
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4), consistent with the baseline percentages of apoptosis
(Figure 1).
Effect of 25-hydroxycholesterol on the expression of
c-myc, p53 and caspase-3 genes
Addition of 25-HC to the cultures produced a significant
increase in c-myc expression (p < 0.001), with a signifi-
cantly lower increase in SMC-Ch-FO versus SMC-C (p <
0.01) (Figure 2). Addition of 25-HC also produced a
major increase in p53 mRNA (p < 0.001) in all three cul-
ture types (Figure 3). Finally, 25-HC produced a marked
increase in caspase-3 gene expression (Figure 4).
Discussion
The dedifferentiation and proliferation/apoptosis of
SMC in the arterial intima are among changes in early
atherosclerotic lesions, when the disease is still
Figure 2 25-hidroxycholesterol effects on c-myc expression in the cell culture model. c-myc mRNA quantification in SMC cultures (SMC-C,
SMC-Ch, SMC-Ch-FO) and SMC cultures treated with 20 μg/ml 25-hydroxycholesterol for 24 h. mRNA levels were quantified by real-time
semiquantitative reverse-transcription PCR. Results are shown as relative expression ratio of c-myc in SMC cultures with respect to control culture
and expressed in comparison to reference gene b-actin. *P < 0.05, ** P < 0.01, *** P < 0.001 vs. SMC-C, +P < 0.05, ++P < 0.01, +++ P < 0.001 vs.
SMC-C treated with 20 μg/mL 25-hydroxycholesterol.
Figure 3 25-hidroxycholesterol effects on p53 expression in the cell culture model. p53 mRNA quantification in SMC cultures (SMC-C,
SMC-Ch, SMC-Ch-FO) and SMC cultures treated with 20 μg/mL 25-hydroxycholesterol for 24 h. mRNA levels were quantified by real-time
semiquantitative reverse-transcription PCR. Results are shown as relative expression ratio of p53 in SMC cultures with respect to control culture
and expressed in comparison to reference gene b-actin. *P < 0.05, ** P < 0.01, *** P < 0.001 vs. SMC-C, +P < 0.05, ++P < 0.01, +++ P < 0.001 vs.
SMC-C treated with 20 μg/mL 25-hydroxycholesterol.
Perales et al. Lipids in Health and Disease 2010, 9:70
http://www.lipidworld.com/content/9/1/70
Page 6 of 9reversible [37,38]. The very low level of apoptosis shown
in SMC in this study is similar to the 4% death rate
usually observed in cultured cells. These data are in
agreement with previous reports that cultured SMC
from the arterial media, even those from atherosclerotic
plaque, show no apoptosis in culture, unlike SMC from
the intima [39]. In early atherosclerosis, cells in the
arterial media that proliferate and migrate, modulating
their phenotype, are protected against apoptosis in some
manner [40].
SMC from chicks fed for 20 days with a cholesterol-
rich diet (SMC-Ch) were more susceptible to apoptosis
than those from control chicks on a standard diet
(SMC-C). This may be due to the accumulation of lipids
in SMC, since lipid accumulation in early atherosclerosis
has been associated with cell proliferation [41,42]. In
contrast, SMC apoptosis levels were lower in chicks fed
for 20 days with fish oil after 20 days on a standard diet
(SMC-Ch-FO) than in the control chicks (p < 0.01).
This finding can be explained in part by a reversal of
the process after the end of the high-cholesterol diet, as
observed in animals with experimental atherosclerotic
plaques [43], and in part by the protective effect of fish
oil against 25-HC-mediated apoptosis, since levels were
even lower than in the control SMC.
The expression of p53 gene was elevated in SMC-Ch-
FO, supporting the proposition that endogenous levels
of p53 protect SMC against apoptosis and possibly
against the development of atherosclerosis [44]. The
main controversy is whether endogenous p53 predomi-
nantly regulates proliferation or apoptosis in SMC. It
has been proposed that p53 is responsible for the quies-
cent state of SMC in the arterial media. During the first
changes in early atherosclerosis, SMC acquire the capa-
city to migrate from the media to the intima, which
requires p53 expression inhibition that may be produced
by mitogens in the vessels [45], whose signals produce a
rapid degradation of endogenous p53 levels. The migra-
tion and proliferation of intima SMC commences at this
time, and they do not re-express p53 when cultured. If
this reduction in endogenous p53 does not occur, the
SMC enter into apoptosis.
It has been reported that c-myc expression interferes
with the control of SMC proliferation [46], and cultured
SMC from atherosclerotic plaque have shown an over-
expression of c-myc with respect to control SMC [47].
Elevated LDL levels have been implicated in the
increased expression of c-myc in atherogenesis [48]. It
should be noted that c-myc is expressed in cells that
actively proliferate, and it is able to induce apoptosis in
the absence of growth factors [49]. Our results are con-
s i s t e n tw i t hf i n d i n g st h a to x i d i z e dL D L s( o x L D L s )p r o -
duce an increase in c-myc expression [50]. Hence,
dysregulation of c-myc causes SMC to proliferate but
simultaneously reduces a-actin and apoptosis levels,
corresponding to a change from a contractile to
s y n t h e t i cS M Cp h e n o t y p e[ 4 6 ] .O u ro b s e r v a t i o no f
lower c-myc levels in SMC-Ch-FO again indicates that
Figure 4 25-hidroxycholesterol effects on caspase-3 expresión in the cell culture model. caspase-3 mRNA quantification in SMC cultures
(SMC-C, SMC-Ch, SMC-Ch-FO) and SMC cultures treated with 20 μg/mL 25-hydroxycholesterol for 24 h. mRNA levels were quantified by
semiquantitative real-time reverse-transcription PCR. Results are shown as relative expression ratio of caspase-3 in SMC cultures with respect to
control culture and expressed in comparison to reference gene b-actin. *P < 0.05, ** P < 0.01, *** P < 0.001 vs. SMC-C, +P < 0.05, ++P < 0.01, ++
+ P < 0.001 vs. SMC-C treated with 20 μg/mL 25-hydroxycholesterol.
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Oxysterols can produce oxidative stress in cells, thereby
activating c-myc gene expression, which is sensitive to
oxidative stress processes. Suppression of oxidative
stress by the administration of anti-oxidants was found
to attenuate this activation and development of the
lesion [51]. Oxidative stress is created in areas of lipid
accumulation, activating c-myc [51]. This study demon-
strated that suppression of oxidative stress by antioxi-
dant administration reduces this activation and
progression of the lesion. Our findings indicate that fish
oil can reduce the increase in c-myc levels observed in
SMC-C and SMC-Ch, possibly through its influence on
the expression of antioxidant genes [52].
The significant increase in p53 mRNA in the three
culture types is consistent with findings that ox-LDLs
(specifically 25-hydroxycholesterol) induce p53 [53]. A
marked increase in Bax protein levels was also observed,
possibly mediated by p53 [35]. These results indicate
that, under our experimental conditions, 25-HC-induced
apoptosis is mediated by p53. Finally, the marked
increase in caspase-3 gene expression induced by 25-HC
is in agreement with reports that oxysterol-induced
apoptosis triggers the activation of caspase-3 protein
[54].
In conclusion, 25-hydroxycholesterol-induced apopto-
sis of SMC is mediated by a significant increase in c-
myc and p53 levels. These changes were generally more
marked in SMC-Ch than in SMC-C, indicating that
dietary cholesterol produces changes in SMC that make
them more susceptible to 25-hydroxycholesterol-
mediated apoptosis. Replacement of a cholesterol-rich
diet with a fish oil-rich diet produces some reversal of
the cholesterol-induced changes, increasing the resis-
tance of SMC to apoptosis.
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